D.E. Shaw & Co
AGN

D.E. Shaw & Co’s Allergan Inc AGN Stock Holding History

D.E. Shaw & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-30,000
Closed -$6.38M – 4400
2014
Q4 		$6.38M Hold
30,000
– – 0.01% 1388
2014
Q3 		$5.35M Sell
30,000
-30,500
-50% -$5.07M 0.01% 1521
2014
Q2 		$10.2M Sell
60,500
-127,200
-68% -$19.8M 0.01% 1088
2014
Q1 		$23.3M Buy
187,700
+5,100
+3% +$621K 0.03% 580
2013
Q4 		$20.3M Sell
182,600
-30,000
-14% -$2.87M 0.03% 682
2013
Q3 		$19.2M Buy
+212,600
New +$19.1M 0.03% 602

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

D.E. Shaw & Co's AGN Position: Q1 2015 in Review

D.E. Shaw & Co sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,757,200 shares — an estimated $374M sold.

D.E. Shaw & Co first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $374M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • D.E. Shaw & Co reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,757,200 Allergan Inc shares in Q1 2015, an estimated $374M.
  • D.E. Shaw & Co first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • D.E. Shaw & Co's Allergan Inc position peaked at $374M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.